Dermatology

Plaque Psoriasis

Expert Roundtables Podcast: The Evolving Treatment Landscape of Oral Therapies for Plaque Psoriasis

expert roundtables by Jeffrey M. Cohen, MD, MPH; Adam Friedman, MD, FAAD; Joel M. Gelfand, MD, MSCE

Overview

Recently, there has been a resurgence in oral therapies for plaque psoriasis, with new options becoming available. This shift highlights a renewed interest in oral treatments within the evolving treatment landscape for plaque psoriasis. Our expert panelists provide updates on these therapies.

References

Carmona-Rocha E, Rusiñol L, Puig L. New and emerging oral/topical small-molecule treatments for psoriasis. Pharmaceutics. 2024;16(2):239. doi:10.3390/pharmaceutics16020239

Drakos A, Torres T, Vender R. Emerging oral therapies for the treatment of psoriasis: a review of pipeline agents. Pharmaceutics. 2024;16(1):111. doi:10.3390/pharmaceutics16010111

Ferrara F, Verduci C, Laconi E, et al. Therapeutic advances in psoriasis: from biologics to emerging oral small molecules. Antibodies (Basel). 2024;13(3):76. doi:10.3390/antib13030076

Yilmaz O, Pinto JP, Torres T. New and emerging oral therapies for psoriasis. Drugs Context. 2024;13:2024-5-6. doi:10.7573/dic.2024-5-6

Profile

Jeffrey M. Cohen, MD, MPH

Assistant Professor
Departments of Dermatology and Biomedical Informatics & Data Science
Director, Psoriasis Treatment Program
Yale School of Medicine
New Haven, CT

Profile

Adam Friedman, MD, FAAD

Professor and Chair of Dermatology
Director, Residency, Translational Research, Hidradenitis Suppurativa, and Supportive Oncodermatology Programs
Department of Dermatology
The George Washington University School of Medicine & Health Sciences
Washington, DC

Profile

Joel M. Gelfand, MD, MSCE

James J. Leyden, MD Professor of Clinical Investigation
Professor of Dermatology and Epidemiology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA